“How do we break the walls of realizing the full potential of organoids and microtissues as an alternative to animal testing?” In line with the motto of the Falling Walls Science Summit 2024 in Be...
Read moreIt shows that low-dose anticoagulants are more effective than antiplatelet drugs.
Read moreThe treatment, successfully tested in mice, will be the basis of a future clinical trial by the biopharmaceutical company Kriya Therapeutics, Inc. ("Kriya")
Read moreUna investigación del Instituto de Biomedicina de Sevilla (IBiS) desarrolla un enfoque innovador basado en la transferencia adoptiva de células de memoria para combatir infecciones por Acinetobacter...
Read moreDesignation recognizes aXess has the potential of providing a more effective vascular access option for dialysis patients, bringing significant advantages over current therapies
Read moreEl cáncer de pulmón representa una de las principales causas de mortalidad por cáncer a nivel mundial. Cada año se diagnostican 2.2 millones de nuevos casos, cuyo pronóstico depende de cómo de t...
Read moreLa Agencia Europea del Medicamento ha cambiado de opinión y respalda la utilización de este medicamento para el tratamiento del alzhéimer en fases iniciales. Aunque reduce un 27 % el deterioro cogn...
Read moreThe p95HER2 protein is found expressed in one third of HER2+ tumors, which represent 4% of all tumors. Led by VHIO investigators, CAR T cells targeting p95HER2 have been engineered to secrete the TECH...
Read moreBiorce, a Barcelona based TechBio company dedicated to transforming clinical trials through artificial intelligence, has announced the successful completion of a €3.5 million funding round. The inve...
Read moreThe IRB Barcelona spin-off Gate2Brain has reached a major milestone in the fight against pediatric brain tumors by obtaining Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) for ...
Read moreNuevas evidencias amplían el papel del ADN extracromosómico en el cáncer y ofrecen una aproximación terapeútica.
Read moreThe Drug Screening Platform at IRB Barcelona was launched 3 years ago to support the scientific community in the early stages of drug development.
Read more